These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 35507150

  • 1. Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.
    Burke GW, Chandar J, Sageshima J, Ortigosa-Goggins M, Amarapurkar P, Mitrofanova A, Defreitas MJ, Katsoufis CP, Seeherunvong W, Centeno A, Pagan J, Mendez-Castaner LA, Mattiazzi AD, Kupin WL, Guerra G, Chen LJ, Morsi M, Figueiro JMG, Vianna R, Abitbol CL, Roth D, Fornoni A, Ruiz P, Ciancio G, Garin EH.
    Pediatr Nephrol; 2023 Jan; 38(1):145-159. PubMed ID: 35507150
    [Abstract] [Full Text] [Related]

  • 2. B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.
    Delville M, Baye E, Durrbach A, Audard V, Kofman T, Braun L, Olagne J, Nguyen C, Deschênes G, Moulin B, Delahousse M, Kesler-Roussey G, Beaudreuil S, Martinez F, Rabant M, Grimbert P, Gallazzini M, Terzi F, Legendre C, Canaud G.
    J Am Soc Nephrol; 2016 Aug; 27(8):2520-7. PubMed ID: 26701979
    [Abstract] [Full Text] [Related]

  • 3. Successful Treatment With Abatacept in Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplant.
    Shah Y, Almeshari K, Aleid H, Broering D, Alahmadi I, Ali T.
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):178-180. PubMed ID: 30777550
    [Abstract] [Full Text] [Related]

  • 4. Abatacept in B7-1-positive proteinuric kidney disease.
    Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW, Mundel P.
    N Engl J Med; 2013 Dec 19; 369(25):2416-23. PubMed ID: 24206430
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of abatacept treatment for focal segmental glomerulosclerosis and minimal change disease: A systematic review of case reports, case series, and observational studies
.
    Hansrivijit P, Puthenpura MM, Ghahramani N.
    Clin Nephrol; 2020 Sep 19; 94(3):117-126. PubMed ID: 32589135
    [Abstract] [Full Text] [Related]

  • 6. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.
    Chang JW, Pardo V, Sageshima J, Chen L, Tsai HL, Reiser J, Wei C, Ciancio G, Burke GW, Fornoni A.
    Transplantation; 2012 Jun 27; 93(12):1238-44. PubMed ID: 22499148
    [Abstract] [Full Text] [Related]

  • 7. Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience.
    Cleper R, Krause I, Bar Nathan N, Mor M, Dagan A, Weissman I, Frishberg Y, Rachamimov R, Mor E, Davidovits M.
    Clin Transplant; 2016 Oct 27; 30(10):1324-1331. PubMed ID: 27490751
    [Abstract] [Full Text] [Related]

  • 8. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
    Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ.
    Pediatr Nephrol; 2015 Mar 27; 30(3):469-77. PubMed ID: 25239302
    [Abstract] [Full Text] [Related]

  • 9. Podocyte-Targeted Treatment for Proteinuric Kidney Disease.
    Mundel P.
    Semin Nephrol; 2016 Nov 27; 36(6):459-462. PubMed ID: 27987545
    [No Abstract] [Full Text] [Related]

  • 10. Unsuccessful Treatment with Abatacept in Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation.
    Kristensen T, Ivarsen P, Povlsen JV.
    Case Rep Nephrol Dial; 2017 Nov 27; 7(1):1-5. PubMed ID: 28203563
    [Abstract] [Full Text] [Related]

  • 11. The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity.
    Burke GW, Mitrofanova A, Fontanella A, Ciancio G, Roth D, Ruiz P, Abitbol C, Chandar J, Merscher S, Fornoni A.
    Front Immunol; 2023 Nov 27; 14():1201619. PubMed ID: 37564655
    [Abstract] [Full Text] [Related]

  • 12. Recurrent Focal Segmental Glomerulosclerosis and Abatacept: Case Report.
    Alkandari O, Nampoory N, Nair P, Atta A, Zakaria Z, Mossad A, Yagan J, Al-Otaibi T.
    Exp Clin Transplant; 2016 Aug 27; 14(4):456-9. PubMed ID: 25432003
    [Abstract] [Full Text] [Related]

  • 13. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2016 Mar 01; 310(5):F335-41. PubMed ID: 26697986
    [Abstract] [Full Text] [Related]

  • 14. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).
    Canaud G, Dion D, Zuber J, Gubler MC, Sberro R, Thervet E, Snanoudj R, Charbit M, Salomon R, Martinez F, Legendre C, Noel LH, Niaudet P.
    Nephrol Dial Transplant; 2010 Apr 01; 25(4):1321-8. PubMed ID: 19773419
    [Abstract] [Full Text] [Related]

  • 15. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis.
    Soyaltın E, Demir BK, Alparslan C, Çamlar SA, Alaygut D, Yavaşcan Ö, Mutlubaş F.
    Turk J Pediatr; 2020 Apr 01; 62(4):663-667. PubMed ID: 32779421
    [Abstract] [Full Text] [Related]

  • 16. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L, Chavez E, Watford D, Tueros L, Correa M, Nair V, Ruiz P, Wahl P, Eddy S, Martini S, Kretzler M, Burke GW, Fornoni A, Merscher S.
    PLoS One; 2019 Apr 01; 14(10):e0222948. PubMed ID: 31581251
    [Abstract] [Full Text] [Related]

  • 17. The role of B7-1 in proteinuria of glomerular origin.
    Novelli R, Benigni A, Remuzzi G.
    Nat Rev Nephrol; 2018 Sep 01; 14(9):589-596. PubMed ID: 29959373
    [Abstract] [Full Text] [Related]

  • 18. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
    Kim JS, Han BG, Choi SO, Cha SK.
    Biomed Res Int; 2016 Sep 01; 2016():1630365. PubMed ID: 27088082
    [Abstract] [Full Text] [Related]

  • 19. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.
    Transpl Int; 2007 Jun 01; 20(6):558-62. PubMed ID: 17433091
    [Abstract] [Full Text] [Related]

  • 20. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF, Kitzler T, Kachurina N, Pessina K, Babayeva S, Bitzan M, Kaskel F, Colmegna I, Alachkar N, Goodyer P, Cybulsky AV, Torban E.
    PLoS One; 2019 Jun 01; 14(5):e0216426. PubMed ID: 31095586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.